Movement Alert|Hinge Health, Inc. Falls 4.19% in Regular Trading, CFO Share Sale Weighs on Sentiment

Market Focus11-13

On November 13, Hinge Health, Inc. fell 4.19% in Regular Trading, trading at $115.705 per share, with turnover of $14.4595 million.

The latest catalyst was an insider transaction disclosure showing Chief Financial Officer James Budge sold 35,907 Class A common shares on November 10 for about $4.37 million, at prices ranging from $119.5214 to $123.3433 per share. After the sale, he still directly held 256,207 shares, but the disclosure nevertheless appeared to pressure near-term market sentiment.

The pullback comes even though Hinge Health, Inc. recently reported better-than-expected third-quarter results, with adjusted earnings and revenue above consensus and full-year revenue guidance raised to $879 million to $881 million. Analysts also lifted price targets after the report, including RBC to $135 while maintaining an Outperform rating, underscoring that the current weakness is more closely tied to the latest insider-sale filing than to operating fundamentals.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment